Neuroderm Ltd (NASDAQ:NDRM): Matt Sirovich And Jeremy Mindich’s Scopia Capital filed an amended 13D.
You can check out Scopia Capital’s latest holdings and filings here.
Please follow Scopia Capital (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Scopia Capital or update its stock holdings.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|Scopia Capital Management||0||205,358||0||205,358||205,358||0.78%|
|Scopia Management, Inc||0||205,358||0||205,358||205,358||0.78%|
Page 1 of 11 – SEC Filing
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
|(Name of Issuer)|
|Ordinary Shares, par value NIS 0.01 per share|
|(Title of Class of Securities)|
|(Date of Event Which Requires Filing of this Statement)|
Check the appropriate box to designate the rule
pursuant to which this Schedule is filed:
|(1)||The remainder of this |
cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
information required in the remainder of this cover page shall not be deemed to be “filed’ for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act (however, see the Notes).